Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing.
Zeng Z, Li W, Zhang D, Zhang C, Jiang X, Guo R, Wang Z, Yang C, Yan H, Zhang Z, Wang Q, Huang R, Zhao Q, Li B, Hu X, Gao L.
Zeng Z, et al. Among authors: zhang c, zhang d, zhang z.
Front Oncol. 2022 May 18;12:893282. doi: 10.3389/fonc.2022.893282. eCollection 2022.
Front Oncol. 2022.
PMID: 35664733
Free PMC article.